Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN350685

ORAI Calcium Release-Activated Calcium Modulator 1 (ORAI1) (C-Term) antibody

Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms CRACM1, ORAT1, TMEM142A, orai-1, Tmem142a, D730049H07Rik, RGD1311873, orai1, tmem142a, tmem142b, im:7146264, zgc:109721, orai2, ORAI1, LOC100218031
»Alternatives C-Term
»Alternatives Rat (Rattus), Mouse (Murine), Human
»Alternatives Rabbit
Clonality Polyclonal
»Alternatives Immunohistochemistry (IHC), Western Blotting (WB)
Pubmed 5 references available
Catalog no. ABIN350685
Quantity 100 µL
454.67 $   Plus shipping costs $45.00
Shipping to
Availability Will be delivered in 7 to 8 Business Days
Immunogen A synthetic peptide from the c-terminal region of rat Orai1 (TMEM142a) conjugated to an immunogenic carrier protein was used as the immunogen. The antigen is homologous in mouse and human.
Specificity Appears to be specific for Orai1.
Purity whole serum
Alternative Name Orai1 (TMEM142a)
Background Function: Ca2+ release-activated Ca2+ (CRAC) channel subunit which mediates Ca2+ influx following depletion of intracellular Ca2+ stores and channel activation by the Ca2+ sensor, STIM1. CRAC channels are the main pathway for Ca2+ influx in T-cells and promote the immune response to pathogens by activating the transcription factor NFAT. Defects in ORAI1 are a cause of severe combined immunodeficiency with CRAC channel dysfunction (CRAC-SCID). SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients with SCID present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Subcellular location: Cell membrane, Multi-pass membrane protein. Also known as: Orai-1, TMEM142a, CRACM1, Calcium release-activated calcium channel protein 1,transmembrane protein 142A.
UniProt Q5M848
Application Notes IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not tested in other applications.
Restrictions For Research Use only
Format Lyophilized
Storage -20 °C
Ota, Suzuki, Nishikawa et al.: "Complete sequencing and characterization of 21,243 full-length human cDNAs." in: Nature genetics, Vol. 36, Issue 1, pp. 40-5, 2003 (PubMed).

Carninci, Kasukawa, Katayama et al.: "The transcriptional landscape of the mammalian genome." in: Science (New York, N.Y.), Vol. 309, Issue 5740, pp. 1559-63, 2005 (PubMed).

Feske, Gwack, Prakriya et al.: "A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function." in: Nature, Vol. 441, Issue 7090, pp. 179-85, 2006 (PubMed).

Soboloff, Spassova, Tang et al.: "Orai1 and STIM reconstitute store-operated calcium channel function." in: The Journal of biological chemistry, Vol. 281, Issue 30, pp. 20661-5, 2006 (PubMed).

Mercer, Dehaven, Smyth et al.: "Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1." in: The Journal of biological chemistry, Vol. 281, Issue 34, pp. 24979-90, 2006 (PubMed).

Alternatives for antigen "ORAI Calcium Release-Activated Calcium Modulator 1 (ORAI1)", type "Antibodies"
Hosts (43), (18), (9)
Reactivities (66), (37), (21), (2), (2), (2), (2)
Applications (66), (40), (29), (13)
Epitopes (28), (12), (5), (2), (2), (2), (2), (1), (1)